CODX Cash Flow Statement & Analysis - Co-Diagnostics Inc.

CODX Cash Flow Statement & Analysis - Co-Diagnostics Inc.

December 2025 - December 2025

Currency in USD

Format (Quarterly, Annual)

cash statement table
Cash Flow	2025-12	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06
Net Income 5YR AVG $()	-$46.90M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Operating Gains Losses	-$683.37K	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Total Depreciation & Amortization	$1.11M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Total Depreciation, Amortization, Depletion	$1.11M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Stock Based Compensation	$2.25M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Other Noncash Items	$135.00K	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Change in Receivables	-$31.80K	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Change in Inventories	$131.27K	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Change in Payables and Accrued Expense	-$3.83M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Changes in Other Working Cap	-$26.06K	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Changes in Working Capital	-$3.17M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Cash from Operations	-$29.14M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B

cash statement table
Cash Flow - Investing	2025-12	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06
Capital Expenditures	-$700.05K	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Free Cash Flow 5YR AVG $()	-$29.84M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Cash from Investing	$26.27M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B

cash statement table
Cash Flow - Financing	2025-12	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06
Common Stock Issuance	$11.80M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Net Common Equity Issued (Purchased)	$11.80M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Cash from Financing	$11.81M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B

cash statement table
Ending Cash	2025-12	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06
Beginning Cash	$2.94M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Change in Cash	$8.95M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B
Ending Cash	$11.88M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B

cash statement table
Additional Items	2025-12	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06	2023-06
Issuance of Capital Stock	$11.80M	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B	106.66 B